Related Experiment Videos
Relaxin-like peptides in cancer
Josh D Silvertown1, Alastair J S Summerlee, Thomas Klonisch
1Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
International Journal of Cancer
|October 2, 2003
Summary
Relaxin and INSL3 hormones influence tumor growth, invasion, and blood vessel formation. Their receptors, LGR7 and LGR8, reveal auto/paracrine actions in cancer, highlighting their etiological roles.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Relaxin-like hormones, including relaxin and INSL3 (insulin-like 3), are involved in tumor cell growth, differentiation, invasion, and neovascularization.
- The discovery of relaxin receptors LGR7 and LGR8 provides evidence for auto/paracrine signaling of these hormones within tumor tissues.
- These findings suggest significant roles for relaxin-like peptides in cancer biology and progression.
Purpose of the Study:
- To review the expression of relaxin and INSL3 in human neoplastic tissues.
- To discuss the etiological roles of these peptide hormones in cancer development.
- To elucidate the cellular pathways mediating the effects of relaxin-like peptides in neoplasia.
Main Methods:
- Literature review of studies on relaxin and INSL3 expression in human cancers.
- Analysis of research on the functions of relaxin and INSL3 receptors (LGR7, LGR8) in tumor biology.
- Synthesis of current knowledge on cellular signaling pathways linking these hormones to cancer progression.
Main Results:
- Relaxin and INSL3 are expressed in various human neoplastic tissues.
- Relaxin-like peptides influence tumor cell growth, differentiation, and invasion.
- Relaxin promotes angiogenesis via nitric oxide and vascular endothelial growth factor (VEGF) and facilitates invasion by modulating matrix metalloproteinases (MMPs).
Conclusions:
- Relaxin and INSL3 play significant etiological roles in cancer.
- The identified receptors and signaling pathways provide a basis for understanding relaxin-like actions in tumor biology.
- Further research into these hormones may offer novel therapeutic strategies for cancer treatment.